Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Johnson & Johnson’s McNeil Unit Recalls Infants’, Children’s Liquid Tylenol

By Pharmaceutical Processing | September 25, 2009

NEW YORK (AP) — Johnson & Johnson’s McNeil unit said Thursday it is voluntarily recalling 57 lots of infants’ and children’s liquid Tylenol products because of possible bacterial contamination. The products being recalled were made between April and June and include nearly two dozen varieties, including Children’s Tylenol Suspension 4 oz. Grape, Infants’ Tylenol Grape Suspension Drops 1/4 oz. and Children’s Tylenol Plus Cold/Allergy 4 oz. Bubble Gum. Johnson & Johnson said it has contacted wholesalers and retailers about the recall. An inactive ingredient didn’t meet internal testing requirements, the company said, and B. cepacia bacteria were detected in a portion of raw material that went unused in the finished product. The company said in a letter that no bacteria were found in the finished product, and that the likelihood of a serious medical event is remote. However, in consultation with the Food and Drug Administration, the company decided to recall the products. “It was decided, as a precaution, to recall all product that utilized any of the raw material manufactured at the same time as the raw material that tested positive for the bacteria,” the company said. Consumers with questions should call McNeil’s consumer call center at 1-800-962-5357. A full list of the 21 recalled products and their lot numbers can be seen at: http://www.tylenol.com/page.jhtml?idtylenol/news/subpchildinfantnews.inc Consumers can find lot numbers on the bottom of the product’s box and on the sticker that surrounds the product’s bottle.

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Novartis logo
Novartis temporarily halts production of two radioligand therapy medicines
Capsules
Herbal supplements recalled as a result of undeclared sildenafil and tadalafil
Gilead Sciences
Gilead identifies counterfeit versions of two of its HIV drugs

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards